Nancy S Green

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. pmc Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea
    Nancy S Green
    Department of Pediatrics, Columbia University, New York, New York, USA
    PLoS ONE 8:e55709. 2013
  2. pmc Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease
    Nancy S Green
    Department of Pediatrics, Columbia University Medical Center, New York, New York 10032, USA
    Pediatr Blood Cancer 56:177-81. 2011
  3. pmc Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease
    Suzette O Oyeku
    Department of Pediatrics, Division of General Pediatrics, Children s Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA
    Pediatr Blood Cancer 60:653-8. 2013
  4. pmc Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyurea
    Katherine L Ender
    Pediatric Hematology, Columbia University Medical Center, NY 10032, USA
    J Pediatr Hematol Oncol 33:496-9. 2011
  5. ncbi request reprint Incomplete follow-up of hemoglobinopathy carriers identified by newborn screening despite reporting in electronic medical records
    Mara Burney
    School of Nursing, Columbia University Medical Center, New York, New York 10032, USA
    J Natl Med Assoc 103:852-6. 2011
  6. doi request reprint Emerging science of hydroxyurea therapy for pediatric sickle cell disease
    Nancy S Green
    Division of Pediatric Hematology Oncology Stem Cell Transplantation, Department of Pediatrics, Columbia University, New York, New York
    Pediatr Res 75:196-204. 2014
  7. doi request reprint A framework for key considerations regarding point-of-care screening of newborns
    Alex R Kemper
    Department of Pediatrics, Duke University, Durham, North Carolina, USA
    Genet Med 14:951-4. 2012
  8. pmc Awareness of sickle cell among people of reproductive age: Dominicans and African Americans in northern Manhattan
    Saira Siddiqui
    Department of Pediatrics, Columbia University, 622 W 168th St, Rm VC4 412, New York, NY 10032, USA
    J Urban Health 89:53-8. 2012

Collaborators

Detail Information

Publications8

  1. pmc Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea
    Nancy S Green
    Department of Pediatrics, Columbia University, New York, New York, USA
    PLoS ONE 8:e55709. 2013
    ..The sole approved pharmacologic therapy for this disease is hydroxyurea, with effects largely attributable to induction of fetal hemoglobin...
  2. pmc Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease
    Nancy S Green
    Department of Pediatrics, Columbia University Medical Center, New York, New York 10032, USA
    Pediatr Blood Cancer 56:177-81. 2011
    ..We review these methods and findings, and speculate on applying pharmaco-genetics to optimize hydroxyurea therapy aimed at increasing HbF...
  3. pmc Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease
    Suzette O Oyeku
    Department of Pediatrics, Division of General Pediatrics, Children s Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA
    Pediatr Blood Cancer 60:653-8. 2013
    ..Hydroxyurea (HU) is highly effective treatment for sickle cell disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit...
  4. pmc Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyurea
    Katherine L Ender
    Pediatric Hematology, Columbia University Medical Center, NY 10032, USA
    J Pediatr Hematol Oncol 33:496-9. 2011
    ..If generalizable, our results support combining these 2 groups in future clinical and translational analyses focused on HbF and response to HU in this ethnically mixed patient population...
  5. ncbi request reprint Incomplete follow-up of hemoglobinopathy carriers identified by newborn screening despite reporting in electronic medical records
    Mara Burney
    School of Nursing, Columbia University Medical Center, New York, New York 10032, USA
    J Natl Med Assoc 103:852-6. 2011
    ..Has the recent availability of newborn hemoglobinopathy screening results within patient electronic medical records (EMR) of birth hospitals facilitated follow-up by primary care pediatric providers?..
  6. doi request reprint Emerging science of hydroxyurea therapy for pediatric sickle cell disease
    Nancy S Green
    Division of Pediatric Hematology Oncology Stem Cell Transplantation, Department of Pediatrics, Columbia University, New York, New York
    Pediatr Res 75:196-204. 2014
    ..Understanding the genetic and other factors underlying the variability in therapeutic effects of HU for pediatric SCD is critical for prospectively predicting good responders and for designing other effective therapies. ..
  7. doi request reprint A framework for key considerations regarding point-of-care screening of newborns
    Alex R Kemper
    Department of Pediatrics, Duke University, Durham, North Carolina, USA
    Genet Med 14:951-4. 2012
    ....
  8. pmc Awareness of sickle cell among people of reproductive age: Dominicans and African Americans in northern Manhattan
    Saira Siddiqui
    Department of Pediatrics, Columbia University, 622 W 168th St, Rm VC4 412, New York, NY 10032, USA
    J Urban Health 89:53-8. 2012
    ..Y.C. community affected by sickle conditions frequently lack basic relevant information, with larger information gaps among Dominicans. Expanded efforts are warranted to inform young adults of diverse affected communities...